The global mobile gamma cameras market is on a trajectory of impressive growth, with expectations to achieve a valuation of USD 59.5 billion by the end of 2023. This momentum is driven by a pronounced focus on patient-centric care, which is anticipated to fuel a compound annual growth rate (CAGR) of 4.2% from 2023 to 2033, potentially elevating the market value to USD 89.8 billion by the conclusion of the forecast period.
Key Growth Drivers:
One of the pivotal factors propelling this expansion is the increasing adoption of environmentally friendly healthcare solutions. Mobile gamma cameras, featuring energy-efficient attributes and reduced radiation exposure, are aligning with global sustainability initiatives, thereby amplifying market demand.
The market’s competitive landscape is evolving dynamically, characterized by strategic mergers, acquisitions, and partnerships among leading industry players. These collaborations are set to stimulate innovation, enhance product offerings, and further drive market growth.
Training and educational programs designed to bolster healthcare professionals’ expertise in nuclear medicine and gamma camera operation are expected to play a crucial role in stimulating market advancement. Additionally, the rise of mobile and remote healthcare clinics, particularly in rural and underserved regions, is creating a growing demand for portable imaging solutions like mobile gamma cameras.
Technological Integration and Applications:
Mobile gamma cameras are increasingly utilized in conjunction with other imaging modalities such as CT (Computed Tomography) and MRI (Magnetic Resonance Imaging) to provide more comprehensive diagnostic assessments. Their integration with electronic health records (EHRs) and Picture Archiving and Communication Systems (PACS) enhances data management and accessibility, significantly improving their overall utility.
The application of mobile gamma cameras extends to post-treatment monitoring in nuclear medicine therapies, including radioiodine therapy for thyroid disorders. This expanded use is bolstered by the need for preparedness for potential health crises or bioterrorism threats, leading to the establishment of mobile medical units equipped with diagnostic tools like mobile gamma cameras.
Market Insights:
- The global mobile gamma cameras market was valued at USD 56.3 billion by the end of 2022.
- From 2018 to 2022, market demand grew at a CAGR of 4.0%.
- India held a market share of 15.0% in 2022.
- The hospitals segment accounted for a 41.0% market share in 2022.
- From 2023 to 2033, the market is projected to grow at a CAGR of 4.2%.
- By 2033, the market value is expected to reach USD 89.8 billion.
Future Prospects:
The burgeoning growth of telehealth services, including telemedicine and teleradiology, is anticipated to significantly contribute to the expansion of the mobile gamma cameras market in the near future, according to FMI analysts.
Access Detailed Market Data: Download the Complete Mobile Gamma Cameras Market Report Now
Competitive Landscape:
Key players in the mobile gamma cameras market include Digirad Corporation, DDD-Diagnostic A/S, Dilon Technologies, Inc., Spectrum Dynamics Medical, GAEDE Medizinsysteme GmbH, Beijing Hamamatsu Photon Techniques Inc., MIE America, Mediso, CLERAD, and CardiArc.
Recent Developments:
- 2023: Nuclear Fields launched the Gamma-Boy, a portable and affordable mobile gamma camera designed for diverse settings including hospitals, clinics, and research laboratories.
- 2022: Siemens Healthineers introduced the Symbia Intevo Bold, a high-resolution mobile gamma camera intended for SPECT and PET nuclear medicine imaging procedures.
- 2021: Dilon Technologies unveiled the Ranger Vision 2.0, a lightweight and compact mobile gamma camera for use in hospitals, clinics, and ambulances. Gamma Medica also launched the LumaGEM 360, a high-resolution mobile gamma camera for SPECT and PET imaging.
Segmentation Analysis:
- Product Type: Single Head, Double Head, Triple Head, Hand Held
- Indication: Cardiac Imaging, Breast Imaging, Hepatobiliary Imaging, GI Imaging, Renal Imaging, Brain Imaging, Others
- End-User: Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes, Specialized Clinics
- Region: North America, Latin America, Western Europe, Eastern Europe, South Asia & Pacific, East Asia, The Middle East & Africa
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
